Phase II Study of S-1 Plus Either Irinotecan or Docetaxel for Non-small Cell Lung Cancer Patients Treated with More Than Three Lines of Treatment

PURPOSE: This study was designed to evaluate the efficacy of a combination treatment of S-1 plus either irinotecan or docetaxel for advanced/metastatic non-small cell lung cancer (NSCLC) patients who have already failed 3 or more lines of treatment. MATERIALS AND METHODS: This was a prospective sing...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Dal Yong, Lee, Dae Ho, Jang, Sun-Joo, Kim, Sang-We, Suh, Cheolwon, Lee, Jung Shin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253862/
https://www.ncbi.nlm.nih.gov/pubmed/22247705
http://dx.doi.org/10.4143/crt.2011.43.4.212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253862/
https://www.ncbi.nlm.nih.gov/pubmed/22247705
http://dx.doi.org/10.4143/crt.2011.43.4.212

Ejemplares similares